Literature DB >> 16357171

The shed ectodomain of Nr-CAM stimulates cell proliferation and motility, and confers cell transformation.

Maralice Conacci-Sorrell1, Anna Kaplan, Shani Raveh, Nancy Gavert, Takeshi Sakurai, Avri Ben-Ze'ev.   

Abstract

Nr-CAM, a cell-cell adhesion molecule of the immunoglobulin-like cell adhesion molecule family, known for its function in neuronal outgrowth and guidance, was recently identified as a target gene of beta-catenin signaling in human melanoma and colon carcinoma cells and tissue. Retrovirally mediated transduction of Nr-CAM into fibroblasts induces cell motility and tumorigenesis. We investigated the mechanisms by which Nr-CAM can confer properties related to tumor cell behavior and found that Nr-CAM expression in NIH3T3 cells protects cells from apoptosis in the absence of serum by constitutively activating the extracellular signal-regulated kinase and AKT signaling pathways. We detected a metalloprotease-mediated shedding of Nr-CAM into the culture medium of cells transfected with Nr-CAM, and of endogenous Nr-CAM in B16 melanoma cells. Conditioned medium and purified Nr-CAM-Fc fusion protein both enhanced cell motility, proliferation, and extracellular signal-regulated kinase and AKT activation. Moreover, Nr-CAM was found in complex with alpha4beta1 integrins in melanoma cells, indicating that it can mediate, in addition to homophilic cell-cell adhesion, heterophilic adhesion with extracellular matrix receptors. Suppression of Nr-CAM levels by small interfering RNA in B16 melanoma inhibited the adhesive and tumorigenic capacities of these cells. Stable expression of the Nr-CAM ectodomain in NIH3T3 cells conferred cell transformation and tumorigenesis in mice, suggesting that the metalloprotease-mediated shedding of Nr-CAM is a principal route for promoting oncogenesis by Nr-CAM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16357171     DOI: 10.1158/0008-5472.CAN-05-2647

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Nuclear signalling by tumour-associated antigen EpCAM.

Authors:  Dorothea Maetzel; Sabine Denzel; Brigitte Mack; Martin Canis; Philip Went; Michael Benk; Cuong Kieu; Peer Papior; Patrick A Baeuerle; Markus Munz; Olivier Gires
Journal:  Nat Cell Biol       Date:  2009-01-11       Impact factor: 28.824

2.  NrCAM deletion causes topographic mistargeting of thalamocortical axons to the visual cortex and disrupts visual acuity.

Authors:  Galina P Demyanenko; Thorfinn T Riday; Tracy S Tran; Jasbir Dalal; Eli P Darnell; Leann H Brennaman; Takeshi Sakurai; Martin Grumet; Benjamin D Philpot; Patricia F Maness
Journal:  J Neurosci       Date:  2011-01-26       Impact factor: 6.167

3.  PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis.

Authors:  Lucia B Jilaveanu; Fabio Parisi; Meaghan L Barr; Christopher R Zito; William Cruz-Munoz; Robert S Kerbel; David L Rimm; Marcus W Bosenberg; Ruth Halaban; Yuval Kluger; Harriet M Kluger
Journal:  Clin Cancer Res       Date:  2014-10-14       Impact factor: 12.531

4.  Cancer cells cut homophilic cell adhesion molecules and run.

Authors:  Sonya E L Craig; Susann M Brady-Kalnay
Journal:  Cancer Res       Date:  2010-11-17       Impact factor: 12.701

Review 5.  L1 cell adhesion molecules as regulators of tumor cell invasiveness.

Authors:  Priscila F Siesser; Patricia F Maness
Journal:  Cell Adh Migr       Date:  2009-07-07       Impact factor: 3.405

6.  Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAM-stimulated glioblastoma cell motility and proliferation.

Authors:  Hannah J Anderson; Deni S Galileo
Journal:  Cell Oncol (Dordr)       Date:  2016-02-16       Impact factor: 6.730

7.  A Genome-Wide Study of Single-Nucleotide Polymorphisms in MicroRNAs and Further In Silico Analysis Reveals Their Putative Role in Susceptibility to Late-Onset Alzheimer's Disease.

Authors:  Soraya Herrera-Espejo; Borja Santos-Zorrozua; Paula Alvarez-Gonzalez; Idoia Martin-Guerrero; Marian M de Pancorbo; Africa Garcia-Orad; Elixabet Lopez-Lopez
Journal:  Mol Neurobiol       Date:  2020-09-06       Impact factor: 5.590

Review 8.  L1CAM: a major driver for tumor cell invasion and motility.

Authors:  Helena Kiefel; Sandra Bondong; John Hazin; Johannes Ridinger; Uwe Schirmer; Svenja Riedle; Peter Altevogt
Journal:  Cell Adh Migr       Date:  2012-07-01       Impact factor: 3.405

9.  Analysis of the membrane proteome of ciprofloxacin-resistant macrophages by stable isotope labeling with amino acids in cell culture (SILAC).

Authors:  Nancy E Caceres; Maarten Aerts; Béatrice Marquez; Marie-Paule Mingeot-Leclercq; Paul M Tulkens; Bart Devreese; Françoise Van Bambeke
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

10.  The role of alpha 6 integrin in prostate cancer migration and bone pain in a novel xenograft model.

Authors:  Tamara E King; Sangita C Pawar; Lisa Majuta; Isis C Sroka; Danyel Wynn; Manolis C Demetriou; Raymond B Nagle; Frank Porreca; Anne E Cress
Journal:  PLoS One       Date:  2008-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.